Corlieve Therapeutics SAS Closes Seed Financing to Develop Therapies for Severe Neurological Conditions ...Middle East

PARIS, Nov. 2, 2020 /PRNewswire/ -- Corlieve Therapeutics today announced the closing of its seed financing led by Kurma Partners and IDinvest Partners, together with Pureos Bioventures. Corlieve is focused on developing novel therapeutics for severe neurological disorders. Corlieve's...

Hence then, the article about corlieve therapeutics sas closes seed financing to develop therapies for severe neurological conditions was published today ( Monday 02/11/2020 - 09:11 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Corlieve Therapeutics SAS Closes Seed Financing to Develop Therapies for Severe Neurological Conditions )

Also on site :

• Here’s how 2025 killed old-school diplomacy
• Quantum Computing in Financial Services Market Set to Reach USD 6.3 Billion by 2032 as Banks Move from Experimentation to Quantum Advantage .. DataM Intelligence
• The Board of Directors of SciBase resolves on a previously communicated rights issue of shares of approximately SEK 83 million